LOS ANGELES, Dec. 2, 2013 /PRNewswire/ -- Bruin Biometrics, LLC ("BBI") a medical device company developing innovative, point of care diagnostic devices, announced today the appointment of two new board members and the expansion of the executive team.
Jeff Greiner joins the BBI board after serving 18 years leading Advanced Bionics, a medical device company that developed spinal cord stimulators and cochlear implants. The company was sold for over $3 billion dollars and is now owned by Boston Scientific (neuromodulation division) and Sonova (cochlear implant division).
Eve Kurtin joins the BBI Board with over 20 years of experience as an operating executive and investor in healthcare. Eve is Managing Director of Pacific Venture Group and Senior Advisor of VantagePoint Capital Partners. She is also a founding member of the RAND Health Board of Advisors, an assembly of national leaders working to improve the U.S. healthcare system.
Rob Pecsar joins BBI as Vice President of Research & Development. Rob has previously launched 18 medical products at a variety of companies including Alaris Medical Systems, Cardinal Health, CareFusion, Gen-Probe, IMED, and Infrasonics, Inc.
Armin Beck joins BBI as Vice President of Quality, Regulatory, Manufacturing, and Operations. He has over 30 years experience leading international commercial product launches and most recently directed Quality Assurance, Regulatory, and Clinical Affairs at Cardica, Inc.
Mark Bruns joins BBI as Vice President of Commercial Operations and Sales. Mark has over 30 years of experience, most recently as a transformational leader in sales and marketing at Alaris Medical Systems, Cardinal Health, and CareFusion.
Sally Grigoriev joins BBI as Senior Advisor, Operations. Sally was previously Senior Vice President of Manufacturing and Operations at CareFusion and Cardinal Health. She has over 25 years of R&D, Quality, Regulatory, Manufacturing, and Operations experience within the medical device industry.
BBI Chief Executive Martin Burns commented, "We have been extremely diligent about finding the right people who understand BBI's strategy and also have the talent to execute upon BBI's business goals. Our combined team has launched over 30 medical products and technologies, and we are united in our mission to solve pressing clinical challenges."